Back to results
US 2020/0392235 A1Published application
Novel il-15 prodrugs and methods of use thereof
AssigneeAskGene Pharma Inc.
InventorsYuefeng LU, Chunxiao YU, Jian-Feng LU
Life of this patent
Estimating the term…
Abstract
Provided herein are IL-15 cytokine prodrugs and methods of making and using thereof.
Claims41
A prodrug comprising an IL-15 cytokine moiety (A), a masking moiety (M), a carrier moiety (C), and a Sushi domain (S), wherein
- the masking moiety binds to the IL-15 cytokine moiety and inhibits a biological activity of the IL-15 cytokine moiety,
- the masking moiety is fused to the carrier moiety,
- the Sushi domain is fused to the carrier moiety, and
- the IL-15 cytokine moiety is fused to the Sushi domain.
1 more element
A prodrug comprising an IL-15 cytokine moiety (A), a masking moiety (M), a carrier moiety (C), and a Sushi domain (S), wherein
- the masking moiety binds to the IL-15 cytokine moiety and inhibits a biological activity of the IL-15 cytokine moiety,
- the IL-15 cytokine moiety is fused to the carrier moiety,
- the Sushi domain is fused to the carrier moiety, and
- the masking moiety is fused to the Sushi domain.
1 more element
(canceled)
A prodrug comprising an IL-15 cytokine moiety (A), a masking moiety (M), a carrier moiety (C), and optionally a Sushi domain (S), wherein
- the masking moiety comprises an antibody fragment that binds to the IL-15 cytokine moiety and inhibits a biological activity of the IL-15 cytokine moiety, and
- the masking moiety is fused to the carrier moiety, to the IL-15 cytokine moiety, or to the Sushi domain through a peptide linker.
(canceled)
25-26. (canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.